Hacker News
- An MRNA Vaccine Against SARS-CoV-2 – Preliminary Report https://www.nejm.org/doi/full/10.1056/NEJMoa2022483 2 comments
- Results of recently published vaccine trial: what can I take away from the results? What does this mean for the next clinical trial? https://www.nejm.org/doi/full/10.1056/NEJMoa2022483 6 comments askscience
- Most advanced mRNA Vaccine against SARS-CoV-2 produced robust immune response in all patients https://www.nejm.org/doi/full/10.1056/nejmoa2022483 1291 comments science
Linking pages
- mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants | Scientific Reports https://www.nature.com/articles/s41598-022-06629-2 1849 comments
- Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2109522 1533 comments
- Dolly Parton helped fund Moderna's Covid-19 vaccine research | CNN https://edition.cnn.com/2020/11/17/entertainment/dolly-parton-covid-moderna-vaccine-trnd/index.html 164 comments
- Dolly Parton partially funded Moderna's coronavirus vaccine thanks to her friend Dr. Naji Abumrad - The Washington Post https://www.washingtonpost.com/nation/2020/11/18/dolly-parton-moderna-vaccine-abumrad-covid/ 53 comments
- US government strikes $1.525 billion deal with Moderna for 100 million doses of its Covid-19 vaccine | CNN https://www.cnn.com/2020/08/11/health/moderna-vaccine-government-deal/index.html 29 comments
- Dr. Fauci Says Early Results from Coronavirus Vaccine Are 'Very Good News' https://people.com/health/phase-1-results-in-experimental-coronavirus-vaccine-prove-promising/ 21 comments
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/nejmoa2035389 18 comments
- Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia - The Lancet https://www.thelancet.com/journals/lancet/article/piis0140-6736(20)31866-3/fulltext 15 comments
- Robert F. Kennedy Jr. on Vaccines, COVID and Dr. Fauci: 'I Read the Science' https://www.newsweek.com/robert-f-kennedy-jr-vaccines-covid-dr-fauci-i-read-science-1572688 13 comments
- COVID vaccine side effects: Headache, fatigue, aches are normal https://www.usatoday.com/story/news/health/2020/12/04/covid-vaccine-side-effects-fatigue-aches-normal/3813934001/ 10 comments
- The truth about vaccines - UnHerd https://unherd.com/2020/07/dont-dismiss-the-anti-vaxxers/ 9 comments
- These 4 Covid-19 Vaccines Are Closest to Becoming Reality | WIRED https://www.wired.com/story/these-4-covid-19-vaccines-are-closest-to-becoming-reality/ 7 comments
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/nejmc2103916 6 comments
- COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System: A Target Trial Emulation Study: Annals of Internal Medicine: Vol 175, No 3 https://www.acpjournals.org/doi/10.7326/M21-3256 5 comments
- Peter Doshi: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data - The BMJ https://blogs.bmj.com/bmj/2020/11/26/peter-doshi-pfizer-and-modernas-95-effective-vaccines-lets-be-cautious-and-first-see-the-full-data/ 5 comments
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | NEJM https://www.nejm.org/doi/10.1056/nejmoa2034201 4 comments
- COVID vaccine trials: Black Americans, people of color are vital https://www.usatoday.com/story/news/health/2020/08/20/covid-19-vaccine-trials-need-diverse-volunteers/3297954001/ 3 comments
- Track COVID-19 Vaccines Advancing Through Clinical Trials | The Scientist Magazine® https://www.the-scientist.com/news-opinion/covid-19-vaccine-frontrunners-67382 3 comments
- Covid-19 Vaccines With ‘Minor Side Effects’ Could Still Be Pretty Bad | WIRED https://www.wired.com/story/covid-19-vaccines-with-minor-side-effects-could-still-be-pretty-bad/ 3 comments
- Vaccines | Free Full-Text | Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand https://www.mdpi.com/2076-393X/9/1/3 1 comment
Related searches:
Search whole site: site:www.nejm.org
Search title: An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM
See how to search.